Growth stocks are taking a hit now that the market is in a correction. Biotechs saw a recent sell-off over concerns that the sector was overheating, but biotechs and medical stocks are among leading big-cap stocks. IBD’s Big Cap Screen of the Day lists large stocks with strong earnings and price performance. Actavis (ACT), Alexion Pharmaceuticals (ALXN), Biogen (BIIB), Allergan (AGN) and Novo Nordisk (NVO) are featured on the screen. “If you look
With latest the earnings season on the books, the IBD 50 saw significant changes vs. the start of the reporting period, with numerous newcomers and others rising quickly up the list. Today’s IBD 50 includes recent additions KapStone Paper & Packaging (KS), Ubiquiti Networks (UBNT) and Anika Therapeutics (ANIK) . Meantime, Alexion Pharmaceuticals (ALXN) shot up from No. 44 in early January to the list’s upper echelon. Ubiquiti, No. 2 on this week’s
Alexion Pharmaceuticals (ALXN) stock got another price target hike but took a breather on Tuesday, a day after the Cheshire, Conn.-based drug company raised its 2014 sales and profit guidance. Alexion stock was down more than 1%, near 177, in afternoon trading on the stock market today. On Monday, the stock rose 7% on its new guidance and a reimbursement deal with France. Alexion said Monday it had concluded discussions with the French government